A M Huelskamp - Concepedia

Author

A M Huelskamp

Johns Hopkins University

Also Known As

A M Huelskamp, A.M. HUELSKAMP, ANNE-MARIE HUELSKAMP, Ann Marie Huelskamp

Publications

428

Citations

H-Index

Concepts

All Affiliations

Johns Hopkins University

About

A M Huelskamp is an author at Johns Hopkins University specializing in oncology, breast cancer, and medicine.

Top Concepts

#	Concept	H-Index	Publications	Citations
1	Medicine	3	3	53
2	Health Sciences	1	1	11
3	Cell Biology	1	1	31
4	Cellular Therapies	1	1	31
5	Immunology	1	1	31

A M Huelskamp

Publications

422

Citations

H-Index

Page 1

	Year	Citations
Predictive factors for peripheral-blood progenitor-cell collections using a single large-volume leukapheresis after cyclophosphamide and granulocyte-macrophage colony-stimulating factor mobilization. José Luís Passos‐Coelho, H. Braine, Janice M. Davis, Journal of Clinical Oncology	1995	91
Phase I trial of interferon gamma to potentiate cyclosporine-induced graft-versus-host disease in women undergoing autologous bone marrow transplantation for breast cancer. Georgia B. Vogelsang, RJ Jones, Evan R. Farmer, Journal of Clinical Oncology	1994	81
Phase I trial of intravenous cyclosporine to induce graft-versus-host disease in women undergoing autologous bone marrow transplantation for breast cancer. Georgia B. Vogelsang, Roy Beveridge, ER Farmer, Journal of Clinical Oncology	1993	69
Large-Volume Leukapheresis Using Regional Citrate Anticoagulation to Collect Peripheral Blood Progenitor Cells José Luís Passos‐Coelho, H. Braine, Susan Wright, Journal of Hematotherapy	1995	46
Similar breast cancer cell contamination of single-day peripheral-blood progenitor-cell collections obtained after priming with hematopoietic growth factor alone or after cyclophosphamide followed by growth factor. José Luís Passos‐Coelho, Amy A. Ross, Daniel Kahn, Journal of Clinical Oncology	1996	46
Phase I and pharmacologic study of the alkylating agent modulator novobiocin in combination with high-dose chemotherapy for the treatment of metastatic breast cancer. Derek Armstrong, A M Huelskamp, K Ohly, Journal of Clinical Oncology	1995	36
Administration of human recombinant granulocyte colony-stimulating factor (filgrastim) accelerates granulocyte recovery following high-dose chemotherapy and autologous marrow transplantation with 4-hydroperoxycyclophosphamide-purged marrow in women with metastatic breast cancer. Jeffrey Davis, José Luís Passos‐Coelho, SJ Noga, PubMed Cell TherapyImmunologyPathologyMetronomic ChemotherapyMarrow Infusion	1993	31
Sixteen week dose intense chemotherapy for inoperable, locally advanced breast cancer Deborah K. Armstrong, John H. Fetting, Nancy E. Davidson, Breast Cancer Research and Treatment Advanced Breast CancerSurgical OncologyBreast OncologyMedicineBreast Cancer	1993	11
Comparative Analysis of Breast Cancer Contamination in Mobilized and Nonmobilized Hematopoietic Grafts Andrew Ross, T J Layton, Anita B. Ostrander, Journal of Hematotherapy Breast OncologyTransplantationMedicineBreast Cancer ContaminationHematology	1996	11

Page 1